Arkema Balance Sheet Health
Financial Health criteria checks 4/6
Arkema has a total shareholder equity of €7.4B and total debt of €4.3B, which brings its debt-to-equity ratio to 57.3%. Its total assets and total liabilities are €14.3B and €6.9B respectively. Arkema's EBIT is €440.0M making its interest coverage ratio 6.5. It has cash and short-term investments of €2.0B.
Key information
57.34%
Debt to equity ratio
€4.26b
Debt
| Interest coverage ratio | 6.5x |
| Cash | €1.95b |
| Equity | €7.42b |
| Total liabilities | €6.88b |
| Total assets | €14.30b |
Recent financial health updates
These 4 Measures Indicate That Arkema (EPA:AKE) Is Using Debt Reasonably Well
Jul 27
Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet
Feb 26We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt
Jul 16Is Arkema (EPA:AKE) A Risky Investment?
Mar 29Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet
Dec 30Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?
Sep 07Recent updates
There May Be Reason For Hope In Arkema's (EPA:AKE) Disappointing Earnings
Nov 16Arkema S.A. (EPA:AKE) Just Reported, And Analysts Assigned A €66.94 Price Target
Nov 12Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?
Aug 27Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 06These 4 Measures Indicate That Arkema (EPA:AKE) Is Using Debt Reasonably Well
Jul 27Potential Upside For Arkema S.A. (EPA:AKE) Not Without Risk
Jul 05Arkema (EPA:AKE) Is Increasing Its Dividend To €3.60
May 23Arkema S.A. Just Missed EPS By 78%: Here's What Analysts Think Will Happen Next
May 10Arkema (EPA:AKE) Is Paying Out A Larger Dividend Than Last Year
May 07What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?
May 02Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.60
Apr 11A Piece Of The Puzzle Missing From Arkema S.A.'s (EPA:AKE) Share Price
Mar 28There May Be Reason For Hope In Arkema's (EPA:AKE) Disappointing Earnings
Mar 07Arkema S.A. Just Missed Earnings - But Analysts Have Updated Their Models
Mar 02Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet
Feb 26Take Care Before Diving Into The Deep End On Arkema S.A. (EPA:AKE)
Dec 23
Specialty Materials And Renewable Energy Initiatives Ignite Earnings Growth And Margin Expansion
Strategic projects and acquisitions aim to enhance Arkema's earnings growth and stability, leveraging mega trends in energy and healthcare.At €75.00, Is It Time To Put Arkema S.A. (EPA:AKE) On Your Watch List?
Dec 02Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 09Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality
Aug 08Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 05We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt
Jul 16Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year
May 13Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50
Apr 25Is Arkema (EPA:AKE) A Risky Investment?
Mar 29Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50
Mar 08Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 02Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet
Dec 30An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued
Dec 15Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?
Nov 29Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?
Sep 07Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?
Aug 20Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?
Aug 02Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt
May 28Financial Position Analysis
Short Term Liabilities: AKE's short term assets (€4.9B) exceed its short term liabilities (€1.6B).
Long Term Liabilities: AKE's short term assets (€4.9B) do not cover its long term liabilities (€5.3B).
Debt to Equity History and Analysis
Debt Level: AKE's net debt to equity ratio (31%) is considered satisfactory.
Reducing Debt: AKE's debt to equity ratio has increased from 53.4% to 57.3% over the past 5 years.
Debt Coverage: AKE's debt is well covered by operating cash flow (23%).
Interest Coverage: AKE's interest payments on its debt are well covered by EBIT (6.5x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/24 19:16 |
| End of Day Share Price | 2025/12/24 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Arkema S.A. is covered by 32 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gaurav Jain | Barclays |
| Katie Richards | Barclays |
| James Stewart | Barclays |